Contract HHSD200201692408C
Golden State Medical Supply, Inc. · Department Of Health And Human Services · September 24, 2020
Golden State Medical Supply, Inc. was awarded a federal contract by Department Of Health And Human Services (Office Of Assistant Secretary For Preparedness And Response) on September 24, 2020 for $10.98 million of work in pharmaceutical preparation manufacturing. It was awarded under full and open competition. The contract has been modified 1 time since the base award It uses firm fixed-price contract pricing. The most recent modification was on September 24, 2021. If all options are exercised, the contract could reach $22.34 million.
Contract details
- PIID
- HHSD200201692408C
- Award type
- Definitive Contract
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Medical And Surgical Instruments, Equipment, And Supplies
- First action
- September 24, 2020
- Latest action
- September 24, 2021
Description
PHARM AND MED SUPPLIES
Modification timeline
-
September 24, 2021Mod P00010 · Exercise An Option$11.75M
-
September 24, 2020Mod P00008 · Exercise An Option$11.75M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | Department Of Health And Human Services | March 31, 2026 | $122.8K |
| Four Points Technology, L.L.C. | Department Of Health And Human Services | March 31, 2026 | $246.6K |
| Mckesson Corporation | Department Of Health And Human Services | March 30, 2026 | $9.00M |
| Ase Direct, Inc. | Department Of Health And Human Services | March 30, 2026 | $49.0K |
| Emergent Biosolutions Canada Inc | Department Of Health And Human Services | March 30, 2026 | $256.40M |
| Merck Sharp & Dohme Llc | Department Of Health And Human Services | March 27, 2026 | $361.34M |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract HHSD200201692408C?
Contract HHSD200201692408C is a federal contract awarded to Golden State Medical Supply, Inc. by Department Of Health And Human Services on September 24, 2020 for $10.98 million of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 1 time since the base award.
Who won contract HHSD200201692408C?
Golden State Medical Supply, Inc. won contract HHSD200201692408C from Department Of Health And Human Services.
How much is contract HHSD200201692408C worth?
Contract HHSD200201692408C has obligated $10.98 million to date, with a total potential value of $22.34 million if all options are exercised.